With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...

Moderna stock jumped Tuesday after the first bird-flu death was reported in the U.S.Shares were up 10.6% to $47.10 in early ...

(Bloomberg) -- Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar ...

The challenge of maintaining the earlier growth achieved by US mRNA medicines specialist Moderna through its COVID vaccine ...

Breaktime had help from many donors, including three prominent philanthropic couples: Stephane Bancel and Brenda Bancel (through Bancel Philanthropies), Jeannie Lavine and Jonathan Lavine (through ...

Moderna (MRNA) CEO Stéphane Bancel said that he plans to address any partisan hurdles with the incoming Trump administration’s vaccine and pandemic preparedness policies with “facts and data.” ...

In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year ...

Here are the five things you need to know, including the national day of mourning for Jimmy Carter, California wildfires, Newbury Street rents, and quality goat time ...

On a call with analysts, Bancel specified that the approval came 19 days earlier than in 2023. Sales of the company’s second ...

(CercleFinance.com) - Moderna a publié sur son site internet une lettre aux actionnaires rédigée par son directeur général, Stéphane Bancel ...